Results 291 to 300 of about 892,099 (304)

Good cops turn bad: The contribution of neutrophils to immune-checkpoint inhibitor treatment failures in cancer

Pharmacology & Therapeutics, 2021
exaly  

High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non-small cell lung cancer

Thoracic Cancer, 2019
Nobuyasu Awano, Mari Tone, Takehiro Izumo   +2 more
exaly  

Cancer, checkpoint inhibitors, and confusion

The Lancet Oncology, 2017
Michael, Fernandes, Jan, Brábek
openaire   +2 more sources

Biomarkers for immune checkpoint inhibitors

The Lancet Oncology, 2014
Lysanne A, Lievense, Joost P J J, Hegmans, Joachim G J V, Aerts   +2 more
openaire   +2 more sources

Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor

Journal of Thoracic Oncology, 2019
Youjin Kim, Jong-Mu Sun, Ho Yun Lee
exaly  

Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis

Circulation
Javid J. Moslehi, Gyu Seong Heo, Pan Ma
exaly  

Bispecific checkpoint inhibitor antibodies

2022
BERNETT MATTHEW, MOORE GREGORY, DESJARLAIS JOHN, HEDVAT MICHAEL, BONZON CHRISTINE, NISTHAL ALEX, MUCHHAL UMESH S   +6 more
openaire   +4 more sources

NOVEL IMMUNE CHECKPOINT INHIBITORS

2019
CHEN LIEPING, WANG JUN, BLAIN DAVID A, ZHENG TIMOTHY   +3 more
openaire   +3 more sources

Predictors of Long‐Term Survival in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis

Journal of the American Heart Association
Daniel Zlotoff, Tomas G Neilan, Kerry Lynn Reynolds   +2 more
exaly  

Bispecific checkpoint inhibitor antibodies

2017
BERNETT MATTHEW, MOORE GREGORY, DESJARLAIS JOHN, HEDVAT MICHAEL, BONZON CHRISTINE, NISTHAL ALEX   +5 more
openaire   +4 more sources